Internatl. drug schedulinq
Executive Summary
FDA announced in the Sept. 6 Federal Register that a public meeting will be held Oct. 10 at 8:30 am at the agency's Parklawn Bldg. for consideration of the World Health Organization's proposals on internatl. manufacturing and distribution restrictions for certain stimulant and/or hailucinogenic drugs. Agency noted that the Commission on Narcotic Drugs has decided to include dimethoxybromoamphetamine and methylenedioxyamphetamine in Schedule I. The World Health Organization has recommended that 17 stimulant and/or hailucinogenic drug substances be controlled.